ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years
Gaetano Lauri
Matched on ORCID iD 0000-0003-3530-3573; OpenAlex author ID A5039144320. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 43
2023: 1 paper · 2024: none · 2025: 4 papers · 2026: 2 papers
Papers 7
- Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer. Co-author DOI 10.1002/ueg2.70187↗
- Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis. Co-author DOI 10.1016/j.pan.2026.04.005↗
- The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer. Co-author DOI 10.1016/j.bpg.2025.101991↗
- Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer. Co-author DOI 10.1016/j.dld.2024.05.017↗
- Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. Co-author DOI 10.1016/j.dld.2025.03.009↗
- Author's Reply: Comment on "Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer". Co-author DOI 10.1016/j.dld.2025.06.006↗
- Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression. Co-author DOI 10.3389/fonc.2023.1172606↗
Closest collaborators
The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gabriele Capurso · 7 shared papers, 2023–2026 · strength 1.94
- Paper Author's Reply: Comment on "Association of Smoking with progression from low-risk to high-risk intraductal papillary mu… DOI 10.1016/j.dld.2025.06.006↗
- Paper Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic rev… DOI 10.1016/j.pan.2026.04.005↗
- Paper The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer. DOI 10.1016/j.bpg.2025.101991↗
- Paolo Giorgio Arcidiacono · 6 shared papers, 2023–2026 · strength 1.57
- Paper Author's Reply: Comment on "Association of Smoking with progression from low-risk to high-risk intraductal papillary mu… DOI 10.1016/j.dld.2025.06.006↗
- Paper Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic rev… DOI 10.1016/j.pan.2026.04.005↗
- Paper Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancrea… DOI 10.1016/j.dld.2024.05.017↗
- Matteo Tacelli · 3 shared papers, 2025–2026 · strength 0.80
- Paper Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic rev… DOI 10.1016/j.pan.2026.04.005↗
- Paper Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancrea… DOI 10.1016/j.dld.2024.05.017↗
- Paper Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. DOI 10.1016/j.dld.2025.03.009↗
- Massimo Falconi · 4 shared papers, 2023–2026 · strength 0.76
- Paper Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancrea… DOI 10.1016/j.dld.2024.05.017↗
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. DOI 10.1016/j.dld.2025.03.009↗
- Lívia Archibugi · 3 shared papers, 2025–2026 · strength 0.61
- Paper Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancrea… DOI 10.1016/j.dld.2024.05.017↗
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. DOI 10.1016/j.dld.2025.03.009↗
- Ruggero Ponz de Leon Pisani · 2 shared papers, 2025 · strength 0.41
- Paper Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancrea… DOI 10.1016/j.dld.2024.05.017↗
- Paper Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. DOI 10.1016/j.dld.2025.03.009↗
- Antonio Facciorusso · 1 shared paper, 2026 · strength 0.39
- Stefano Crippa · 2 shared papers, 2023–2025 · strength 0.38
- Paper Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancrea… DOI 10.1016/j.dld.2024.05.017↗
- Paper Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression. DOI 10.3389/fonc.2023.1172606↗
- Krystal C. Mills · 1 shared paper, 2025 · strength 0.37
- Shounak Majumder · 1 shared paper, 2025 · strength 0.37
- Giovanni Marchegiani · 1 shared paper, 2025 · strength 0.23
- Matteo De Pastena · 1 shared paper, 2026 · strength 0.20
- Giuseppe Malleo · 1 shared paper, 2026 · strength 0.20
- Erica Secchettin · 1 shared paper, 2026 · strength 0.20
- Marta Puzzono · 1 shared paper, 2026 · strength 0.20
- Giuliana Sereni · 1 shared paper, 2026 · strength 0.20
- Arianna Dal Buono · 1 shared paper, 2026 · strength 0.20
- Alessandro Zerbi · 1 shared paper, 2026 · strength 0.20
- Raffaele De Luca · 1 shared paper, 2026 · strength 0.20
- Cecilia Binda · 1 shared paper, 2026 · strength 0.20
- Giulia Martina Cavestro · 1 shared paper, 2026 · strength 0.20
- Francesco DE COBELLI · 1 shared paper, 2026 · strength 0.20
- Luigi Laghi · 1 shared paper, 2026 · strength 0.20
- Gabriella Lionetto · 1 shared paper, 2026 · strength 0.20
- Carrara Silvia · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.